Composition
- Active ingredients
- RIFAXIMIN 200MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RIFAXIMIN 550MG · TabletANDA214369-001 · Tentative approval
- RIFAXIMIN 200MG · TabletANDA214370-001 · Tentative approval
- RIFAXIMIN 550MG · TabletANDA219687-001 · Tentative approval
- RIFAXIMIN 550MG · TabletANDA208959-001 · Prescription
- RIFAXIMIN 200MG · TabletThis page
- RIFAXIMIN 200MG · TabletANDA219570-002 · Tentative approval
- RIFAXIMIN 550MG · TabletANDA213713-001 · Tentative approval
- RIFAXIMIN 200MG · TabletANDA218650-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA220451.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Rifaximin
- Dosage form
- Tablet
- Applicant
- Alkem Laboratories Limited
- Status
- Tentative approval
- FDA approval
- 20 Mar 2026
- Application
- ANDA220451-002